© 2025 - 2026
The Life Science Feed. All rights reserved.
A digital publication from Grá & Mawi Media Co.
A 2026 meta-analysis examines SGLT2 inhibitor use in diabetic heart transplant recipients, a population where evidence has been thin and stakes are high.